
News|Articles|September 1, 2003
Cardiovascular benefit of 'polypill' evaluated in BMJ
Three different drugs at half the standard dose are estimated to reduce the risk of stroke by 63% and ischemic heart disease (IHD) events by 46% for those aged 60 to 69 years, according to a study in BMJ. Another study published in the same issue recommends that those with known occlusive vascular disease and everyone aged 55 years or older take a "polypill," including the combination of blood pressure-lowering drugs, a statin, folic acid, and aspirin.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Payer Implications and Final Takeaways from the BE BOLD Trial
2
A conversation with Tiffany Phung, Pharm.D., CSP, about how patient outcomes drive specialty pharmacy strategy
3
Endometriosis increases the risk of Type 2 diabetes
4
The biosimilars market is projected to nearly double — here's where the growth is coming from
5
















